EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-018-3947-x
Abstract: The skeleton is the most common metastatic site in patients with advanced cancer. Pain is a major healthcare problem in patients with bone metastases. Bone-seeking radionuclides that selectively accumulate in the bone are used to… read more here.
Keywords: medicine; bone metastases; eanm guidelines; beta emitting ... See more keywords